PTO/AIA/22 (03-13)
`Approved for use through 11/30/2020. OMB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit displays a valid OMB control number.
`Docket Number (Optional)
`
`PETITION FOR EXTENSION OF TIME UNDER 37 CFR 1.136(a)|1861.2700007/JMC/MSB/LXR
`
`Filed August { 7, 201 8
`Application Number4 5/998,868
` BUPRENORPHINE-WAFER FOR DRUG SUBSTITUTION THERAPY
`Art wnt 61 5
`Examiner To Be Assigned
`
`This is a request under the provisions of 37 CFR 1.136(a) to extend the period for filing a reply in the above-identified application.
`
`The requested extension and fee are as follows (check time period desired and enter the appropriate fee below):
`
`One month (37 CFR 1.17(a)(1))
`
`Two months (37 CFR 1.17(a)(2))
`
`Three months (37 CFR 1.17(a)(3))
`
`Four months (37 CFR 1.17(a)(4))
`Five months (37 CFR 1.17(a)(5))
`
`Fee
`
`$200
`
`$600
`
`$1,400
`
`$2,200
`$3,000
`
`Small Entity Fee
`
`Micro Entity Fee
`
`$100
`
`$300
`
`$700
`
`$1,100
`$1,500
`
`$50
`
`$150
`
`$350
`
`$550
`$750
`
`3000.00
`
`
`
`Applicant asserts small entity status. See 37 CFR 1.27.
`
`Applicant certifies micro entity status. See 37 CFR 1.29.
`Form PTO/SB/15Aor B or equivalent must either be enclosed or have been submitted previously.
`A checkin the amount of the fee is enclosed.
`
`LJ
`
`LJ
`
`LJ
`
`[| Paymentby credit card. Form PTO-2038is attached.
`LI
`The Director has already been authorized to charge feesin this application to a Deposit Account.
`
`The Director is hereby authorized to charge any fees which may be required, or credit any overpayment, to
`Deposit Account Number 19-0036
`
`Payment made via EFS-Web.
`
`WARNING: Information on this form may become public. Credit card information should not be included on this form. Provide
`credit card information and authorization on PTO-2038.
`| am the
`
`[| applicant.
`attorney or agent of record. Registration number 98,885
`
`[| attorney or agent acting under 37 CFR 1.34. Registration number
`/Matthew S. Bodenstein/
`April 8, 2019
`Signature
`Matthew S. Bodenstein
`Typed or printed name
`
`(202)371-2600
`
`Date
`
`Telephone Number
`
`NOTE: This form must be signed in accordance with 37 CFR 1.33. See 37 CFR 1.4 for signature requirements and certifications. Submit
`multiple forms if more than one signature is required, see below*.
`
`* Total of 1
`
`forms are submitted.
`
`This collection of information is required by 37 CFR 1.136(a). The information is required to obtain or retain a benefit by the public, whichisto file (and by the
`USPTOto process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.11 and 1.14. This collection is estimated to take 6 minutes to
`complete, including gathering, preparing, and submitting the completed application form to the USPTO. Timewill vary depending uponthe individual case. Any
`comments on the amountof time you require to complete this form and/or suggestions for reducing this burden should be sentto the Chief Information Officer,
`U.S. Patent and TrademarkOffice, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS
`TO THIS ADDRESS. SEND TO: Mail Stop PCT, Commissionerfor Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`